# DESCRIPTION

## FIELD OF THE INVENTION

- relate to cancer classification

## BACKGROUND OF THE INVENTION

- motivate breast cancer diagnosis

## SUMMARY OF THE INVENTION

- introduce stromal derived prognostic predictor (SDPP)
- describe SDPP gene sets
- outline method for predicting clinical outcome
- describe method for determining prognosis
- outline method for predicting disease outcome
- describe method for diagnosing poor prognosis breast cancer
- summarize SDPP applications

## DETAILED DESCRIPTION OF THE INVENTION

- introduce stroma-derived prognostic predictor (SDPP) for breast cancer
- describe SDPP gene sets and their association with clinical outcome
- explain method for predicting clinical outcome using SDPP gene sets
- provide examples of SDPP gene sets and their application
- discuss advantages of SDPP over existing predictors

### Identifying Classes and Genes for Predicting Clinical Outcome

- describe method for identifying classes according to differential expression in tumor associated versus normal stroma
- explain class discovery and identification of informative genes
- discuss construction of multivariate predictor using Bayes' classifiers
- provide examples of class distinctions and their application

### Cancers

- discuss application of SDPP to different breast cancer subtypes and other cancer types

### Nucleic Acid Compositions

- describe composition comprising isolated nucleic acid sequences complementary to novel SDPP genes

### SDPP Genes and Nucleic Acids

- define SDPP gene sets
- describe novel gene products correlating with disease outcome
- specify isolated nucleic acid sequences and hybridization conditions

### Nucleic Acids, Primers and Probes

- provide compositions of isolated nucleic acid sequences for detecting RNA expression levels
- describe primers and probes for detecting SDPP genes

### Polypeptide Binding Compositions

- describe polypeptide products of SDPP genes and gene sets
- provide compositions of binding agents for detecting polypeptide products
- specify isolated polypeptides, antibodies, and peptide mimetics as binding agents

### Microarrays

- describe microarrays for detecting gene expression levels of SDPP genes

### Methods of Diagnosis

- diagnose breast cancer subtype
- predict clinical outcome
- predict recurrence
- predict metastasis

### Methods of Assigning or Selecting Treatment

- assign treatment based on predicted clinical outcome
- monitor treatment efficacy
- select treatment based on transcriptional profile
- optimize treatment regimen
- tailor treatment to biological responses

## EXAMPLES

### Example 1

- describe sample collection and processing
- perform LCM and RNA isolation
- hybridize RNA on microarrays
- identify differentially expressed genes
- cluster tumor-associated stroma samples
- associate clusters with recurrence and poor outcome
- identify genes differentially expressed between clusters
- construct predictor of prognosis
- evaluate predictor using cross-validation
- compare predictor with publicly available datasets
- validate expression of selected genes by Q-RT-PCR
- perform immunohistochemistry and functional annotation

### Example 2

- integrate multiple predictors using Bayesian network

### Example 3

- identify tumor stroma subtype associated with recurrence and poor outcome
- construct and evaluate predictor using logistic regression and Na√Øve Bayes' classifier

### Example 4

- identify tumor stroma subtype associated with recurrence and poor outcome
- identify genes differentially expressed in poor outcome tumor stroma subtype
- evaluate prognostic predictor by cross-validation and comparison with publicly available datasets
- validate predictor gene expression in tumor stroma

